|
|
|
This is the preliminary program for the 2007 Joint Statistical
Meetings in Salt Lake City, Utah.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2007 Program page |
= Applied Session,
= Theme Session,
= Presenter
270
|
Tue, 7/31/07, 10:30 AM - 12:20 PM | CC-355 C |
| Phase II/III Clinical Trials: Combine or Not to Combine - Topic Contributed - Papers | ||
|
Biopharmaceutical Section, WNAR, ENAR, Biometrics Section, Section on Health Policy Statistics |
||
| Organizer(s): James Hung, Food and Drug Administration | ||
| Chair(s): James Hung, Food and Drug Administration | ||
| 10:35 AM |
Multiplicity in Adaptive Designs —  Willi Maurer, Novartis Pharmaceuticals AG
|
|
| 10:55 AM |
How Much Evidence Is Enough? — Kuang-Kuo Lan, Johnson & Johnson PRD
|
|
| 11:15 AM |
Adaptation of Adaptive Design in Japan — Masahiro Takeuchi, Kitasato University; Hajime Uno, Kitasato University; Fumiaki Takahashi, Kitasato University
|
|
| 11:35 AM |
Stagewise Planning for Clinical Trials from Phase II to Phase III — Sue-Jane Wang, Food and Drug Administration
|
|
| 11:55 AM | Disc: Ralph B. D'Agostino, Sr., Boston University | |
| 12:15 PM | Floor Discussion | |
|
JSM 2007
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |